|
|
| |
Tuesday, 17 February
2015 | ArabMedicare.com | Staff Reporter
|
|
|
| |
|
Photo Caption: Dr. Sherif
Khattab, Head of Oncology
for META Region, Boehringer
Ingelheim.
|
|
| |
Boehringer Ingelheim
appoints Sherif Khattab as
Head of Oncology for the
Middle East, Turkey and
Africa (META) region
(Dubai, UAE) --
Boehringer
Ingelheim, a global
pharmaceutical company
headquartered in
Ingelheim, Germany, has
announced the appointment of
Sherif Khattab as Head of
Oncology for the Middle
East, Turkey and Africa
(META) region.
Based out
of the region’s hub office
in Dubai, Dr. Khattab will
be responsible for the
strategic growth of the
Oncology unit, formulating
and building ground for
launch of Boehringer
Ingelheim new oncology
products in the region, and
developing a solid and
operative oncology team
across the META region. Dr. Khattab
has nearly 20 years
of experience in the
pharmaceutical industry with
expertise in oncology drug
penetration and
commercialization.
Karim El Alaoui Mustapha,
Managing Director Middle
East, Turkey and Africa,
Boehringer Ingelheim, said,
"I'm very excited to have
Sherif join our team. With
his extensive experience in
the pharmaceutical industry,
we are confident of him
leading our oncology
portfolio.” He further
added, "With our new
oncology unit, we hope to be
able to develop new
treatments and further
develop our broad pipeline
in lung cancer. I look
forward to Sherif bringing
that drive and his immense
expertise to Boehringer
Ingelheim to benefit the
many patients we serve now
and in the future."
"I'm eager to be joining
Boehringer Ingelheim", said
Dr. Sherif Khattab, Head of
Oncology, Boehringer
Ingelheim, META. "They have
an unmatched pipeline of
innovative cancer medicines
with a focus on lung cancer,
in addition to several
commercial and consumer
products that have improved
the lives of patients. I
look forward to working with
an effective team and
external collaborators to
continue and outspread the
leading position of
Boehringer Ingelheim in
advancing cancer care."
Dr. Khattab most recently
served Norvatis Oncology,
Middle East cluster where he
launched and led the local
manufacturing project and
grew the strategic portfolio
for Oncology. In his
previous assignments, he has
assumed senior roles at,
AstraZeneca, Schering-Plough
and Eli Lilly Scientific
office rebuilding the
oncology unit and providing
brand support to the MENA
oncology franchise.
Dr. Sherif Khattab is a
medical doctor by education
with Clinical Oncology
practice background, his MBA
studies were in double
majors, Marketing and
Strategic Management from
German University in Cairo.
PRINT
THIS ARTICLE
|
|
|
|
|
|
|
|
